P A Willcox
Overview
Explore the profile of P A Willcox including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shean K, Willcox P, Siwendu S, Laserson K, Gross L, Kammerer S, et al.
Int J Tuberc Lung Dis
. 2008 Sep;
12(10):1182-9.
PMID: 18812049
Setting: Brooklyn Chest Hospital, Western Cape, South Africa. Objective: To evaluate the treatment outcome and 2- and 5-year follow-up of patients treated for multidrug-resistant tuberculosis (MDR-TB) with individualized regimens. Design:...
2.
Petermann W, Odenholt I, Phillips M, Willcox P, Tack K, Trostmann U, et al.
Scand J Infect Dis
. 2002 Jan;
33(11):832-7.
PMID: 11760164
In an open-label, phase 3, randomized, multicenter study, clinafloxacin (200 mg/d) was compared to ceftriaxone (2 g/d; with or without erythromycin) in 527 patients with acute community-acquired bacterial pneumonia (CAP)....
3.
Willcox P
Curr Opin Pulm Med
. 2001 May;
7(3):148-53.
PMID: 11371770
Although it had been appreciated that high levels of antituberculous drug resistance existed in some regions of the world, the full extent of the problem was not known. A combined...
4.
Willcox P
Curr Opin Pulm Med
. 2000 Apr;
6(3):198-202.
PMID: 10782703
There is increasing concern in many countries about the problem of drug-resistant tuberculosis, particularly so because no new classes of drugs have been developed for the treatment of tuberculosis since...
5.
Andersson M, Willcox P
J Infect
. 2000 Mar;
39(3):240-1.
PMID: 10714804
We describe a patient who presented with carpal tunnel syndrome secondary to tuberculous tenosynovitis and who was subsequently shown to have HIV infection. Recognition of this atypical presentation of tuberculosis...
6.
Norrby S, Petermann W, Willcox P, Vetter N, SALEWSKI E
Scand J Infect Dis
. 1998 Nov;
30(4):397-404.
PMID: 9817522
A multinational, multicentre, open, randomised study in hospitalised patients with pneumonia compared levofloxacin 500 mg twice daily with ceftriaxone 4 g i.v. once daily. Levofloxacin patients started on i.v. treatment...
7.
Willcox P, Rayner B, Whitelaw D
QJM
. 1998 Mar;
91(1):41-7.
PMID: 9519211
Despite advances in antimicrobial therapy and intensive care support, Staphylococcus aureus continues to cause significant morbidity and mortality. We studied community-acquired S. aureus bacteraemia in a population where intravenous drug...
8.
Van Leuven M, de Groot M, Shean K, Von Oppell U, Willcox P
Ann Thorac Surg
. 1997 May;
63(5):1368-72; discussion 1372-3.
PMID: 9146329
Background: Over the past decade the incidence of pulmonary disease due to drug-resistant strains of Mycobacterium tuberculosis has increased worldwide. We reviewed our local experience to clarify the benefits and...
9.
Abratt R, Salton D, Malan J, Willcox P
Eur J Cancer
. 1995 Sep;
31A(10):1637-9.
PMID: 7488415
A prospective randomised study was undertaken in patients with limited disease small cell carcinoma of the lung (SCCL), which compared doxorubicin, 50 mg/m2, and vincristine, 2 mg i.v. (intravenously) on...
10.
Abratt R, Willcox P
Int J Radiat Oncol Biol Phys
. 1995 Feb;
31(4):915-9.
PMID: 7860406
Purpose: To prospectively study the changes in lung function in patients with lung carcinoma treated with relatively high doses of irradiation. Methods And Materials: Lung function was assessed prior to...